<DOC>
	<DOC>NCT01447017</DOC>
	<brief_summary>The primary objective of this study is to evaluate safety and tolerability of DPK-060 2% ear drops compared to placebo for DPK-060 ear drops in patients with acute external otitis. The secondary objectives are to evaluate clinical cure and microbiological growth following treatment with DPK-060 2% ear drops compared to placebo for DPK-060 ear drops.</brief_summary>
	<brief_title>A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<criteria>A clinical diagnosis of acute external otitis of a severity degree not requiring specialist care Age 12 years and older Known or suspected perforation of the tympanic membrane A clinical diagnosis of chronic suppurative otitis media, acute otitis media, acute otorrhea or malignant otitis externa Local ear canal abnormalities Congenital abnormalities of the external auditory canal or obstructive bony exostosis Mastoiditis or suppurative noninfectious ear disorders (e.g. cholesteatoma) Malignant tumour of the external auditory canal History of otologic surgery (except for surgery confined to the temporomandibular joint) Seborrheic dermatitis or other dermatological conditions of the external auditory canal that would complicate evaluation Current or prior use (within 7 days) of ear washes using alcohol, vinegar or other astringents Any clinically relevant past or present infectious/viral disease Current infection requiring systemic antimicrobial therapy Current or prior use of systemic (within 14 days) or topical (within 7 days) antibiotics Current or prior use of systemic (within 30 days) or topical (within 7 days) steroids History of immune dysfunction/deficiency and immunosuppressive therapy Diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>